Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Non Operating Income (2021 - 2025)

PAVmed has reported Non Operating Income over the past 5 years, most recently at $4.0 million for Q4 2025.

  • Quarterly results put Non Operating Income at $4.0 million for Q4 2025, down 36.07% from a year ago — trailing twelve months through Dec 2025 was $19.3 million (up 4910.7% YoY), and the annual figure for FY2025 was $19.3 million, down 73.48%.
  • Non Operating Income for Q4 2025 was $4.0 million at PAVmed, up from -$1.2 million in the prior quarter.
  • Over the last five years, Non Operating Income for PAVM hit a ceiling of $24.1 million in Q1 2025 and a floor of -$7.6 million in Q2 2025.
  • Median Non Operating Income over the past 5 years was -$1.2 million (2024), compared with a mean of -$258235.3.
  • Biggest five-year swings in Non Operating Income: tumbled 90750.0% in 2023 and later skyrocketed 717.46% in 2024.
  • PAVmed's Non Operating Income stood at $300000.0 in 2021, then crashed by 90.33% to $29000.0 in 2022, then crashed by 3634.48% to -$1.0 million in 2023, then skyrocketed by 717.46% to $6.3 million in 2024, then plummeted by 36.07% to $4.0 million in 2025.
  • The last three reported values for Non Operating Income were $4.0 million (Q4 2025), -$1.2 million (Q3 2025), and -$7.6 million (Q2 2025) per Business Quant data.